Hai-Zhi Bu
Hai-Zhi Bu has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
Kim Knuth
Department of Metabolic Chemistry, Covance Laboratories Inc., 3301 Kinsman Boulevard, Madison, WI 53704, USA
5 shared publicationsLisa Magis
Department of Metabolic Chemistry, Covance Laboratories Inc., 3301 Kinsman Boulevard, Madison, WI 53704, USA
5 shared publicationsPhilip Teitelbaum
Department of Metabolic Chemistry, Covance Laboratories Inc., 3301 Kinsman Boulevard, Madison, WI 53704, USA
5 shared publications
Latest Publications
- 24 May 2001
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 25 (3-4) , 437-442
High-throughput cytochrome P450 (CYP) inhibition screening via cassette probe-dosing strategy: III. Validation of a direct injection/on-line guard cartridge extraction−tandem mass spectrometry method for CYP2C19 inhibition evaluation
- 24 May 2001
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 25 (3-4) , 437-442
High-throughput cytochrome P450 (CYP) inhibition screening via cassette probe-dosing strategy: III. Validation of a direct injection/on-line guard cartridge extraction−tandem mass spectrometry method for CYP2C19 inhibition evaluation
- 19 April 2001
- Published by Wiley in Rapid Communications in Mass Spectrometry
- Vol. 15 (10) , 741-748
High‐throughput cytochrome P450 (CYP) inhibition screening via a cassette probe‐dosing strategy. VI. Simultaneous evaluation of inhibition potential of drugs on human hepatic isozymes CYP2A6, 3A4, 2C9, 2D6 and 2E1
The inhibition potential of drugs towards five major human hepatic cytochrome P450 (CYP) isozymes (CYP2A6, 3A4, 2C9, 2D6, and 2E1) was investigated via cassette dosing of the five probe substrates (coumarin, midazolam, tolbutamide, dextromethorphan, and chlorzoxazone) in human liver microsomes using a 96‐well plate format. After microsomal incubations had been terminated with formic acid, the five marker metabolites (7‐hydroxycoumarin, 1′‐hydroxymidazolam, 4‐hydroxytolbutamide, dextrorphan, and 6‐hydroxychlorzoxazone) were simultaneously quantified using direct injection/online guard cartridge extraction/tandem mass spectrometry (DI‐GCE/MS/MS). Several advantages resulted from the use of a short C 18 guard cartridge (4 mm in length) for DI‐GCE/MS/MS, including minimal sample preparation, fast online extraction, short analysis time (2.5 min), and minimal source contamination. In addition, this method demonstrated an inter‐day accuracy range from −8.7 − 7.4% with a precision less than 8.3% for the quantification of all the marker metabolites. The inhibition assay for the five CYP isozymes was evaluated using their known selective inhibitors via individual and cassette dosing of the probe substrates. The IC 50 values measured via cassette dosing were consistent with those observed via individual dosing, which were all in agreement with the reported values. In addition, the validated assay was used to evaluate the inhibitory potential of 23 generic drugs (randomly selected) towards the five CYP isozymes. The results suggest the integration of the cassette dosing strategy and the DI‐GCE/MS/MS method can provide a reliable in vitro approach to screening the inhibitory potential of new chemical entities, with maximal throughput and cost‐effectiveness, in support of drug discovery and development. Copyright © 2001 John Wiley & Sons, Ltd.
- 19 April 2001
- Published by Wiley in Rapid Communications in Mass Spectrometry
- Vol. 15 (10) , 741-748
High‐throughput cytochrome P450 (CYP) inhibition screening via a cassette probe‐dosing strategy. VI. Simultaneous evaluation of inhibition potential of drugs on human hepatic isozymes CYP2A6, 3A4, 2C9, 2D6 and 2E1
The inhibition potential of drugs towards five major human hepatic cytochrome P450 (CYP) isozymes (CYP2A6, 3A4, 2C9, 2D6, and 2E1) was investigated via cassette dosing of the five probe substrates (coumarin, midazolam, tolbutamide, dextromethorphan, and chlorzoxazone) in human liver microsomes using a 96‐well plate format. After microsomal incubations had been terminated with formic acid, the five marker metabolites (7‐hydroxycoumarin, 1′‐hydroxymidazolam, 4‐hydroxytolbutamide, dextrorphan, and 6‐hydroxychlorzoxazone) were simultaneously quantified using direct injection/online guard cartridge extraction/tandem mass spectrometry (DI‐GCE/MS/MS). Several advantages resulted from the use of a short C 18 guard cartridge (4 mm in length) for DI‐GCE/MS/MS, including minimal sample preparation, fast online extraction, short analysis time (2.5 min), and minimal source contamination. In addition, this method demonstrated an inter‐day accuracy range from −8.7 − 7.4% with a precision less than 8.3% for the quantification of all the marker metabolites. The inhibition assay for the five CYP isozymes was evaluated using their known selective inhibitors via individual and cassette dosing of the probe substrates. The IC 50 values measured via cassette dosing were consistent with those observed via individual dosing, which were all in agreement with the reported values. In addition, the validated assay was used to evaluate the inhibitory potential of 23 generic drugs (randomly selected) towards the five CYP isozymes. The results suggest the integration of the cassette dosing strategy and the DI‐GCE/MS/MS method can provide a reliable in vitro approach to screening the inhibitory potential of new chemical entities, with maximal throughput and cost‐effectiveness, in support of drug discovery and development. Copyright © 2001 John Wiley & Sons, Ltd.
- 1 April 2001
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 753 (2) , 321-326
High-throughput cytochrome P450 (CYP) inhibition screening via cassette probe-dosing strategy
- 1 April 2001
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 753 (2) , 321-326
High-throughput cytochrome P450 (CYP) inhibition screening via cassette probe-dosing strategy
- 28 February 2001
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 12 (4) , 447-452
High-throughput cytochrome P450 (CYP) inhibition screening via a cassette probe-dosing strategy: V. Validation of a direct injection/on-line guard cartridge extraction–tandem mass spectrometry method for CYP1A2 inhibition assessment
- 28 February 2001
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 12 (4) , 447-452
High-throughput cytochrome P450 (CYP) inhibition screening via a cassette probe-dosing strategy: V. Validation of a direct injection/on-line guard cartridge extraction–tandem mass spectrometry method for CYP1A2 inhibition assessment
- 23 August 2000
- Published by Wiley in Rapid Communications in Mass Spectrometry
- Vol. 14 (17) , 1619-1624
High-throughput cytochrome P450 (CYP) inhibition screening via cassette probe-dosing strategy. I. Development of direct injection/on-line guard cartridge extraction/tandem mass spectrometry for the simultaneous detection of CYP probe substrates and their metabolites
- 23 August 2000
- Published by Wiley in Rapid Communications in Mass Spectrometry
- Vol. 14 (17) , 1619-1624
High-throughput cytochrome P450 (CYP) inhibition screening via cassette probe-dosing strategy. I. Development of direct injection/on-line guard cartridge extraction/tandem mass spectrometry for the simultaneous detection of CYP probe substrates and their metabolites